Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) General Information
Description
Global rights of a cancer medicine, except in Nordics, Russia, and certain countries in Eastern Europe. The medicine is a non-cremophor formulation of the well-known chemotherapeutic agent paclitaxel used to treat women with cancer of the ovary or surrounding structures.
Contact Information
Corporate Office
- Vallongatan 1
- 752 28 Uppsala
- Sweden
Corporate Office
- Vallongatan 1
- 752 28 Uppsala
- Sweden
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) FAQs
-
Where is Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) headquartered?
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is headquartered in Uppsala, Sweden.
-
What industry is Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) in?
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)’s primary industry is Buildings and Property.
-
Is Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) a private or public company?
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is a Private company.
-
What is the current valuation of Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)?
The current valuation of Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is .
-
What is Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)’s current revenue?
The current revenue for Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is .
-
Who are Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)’s investors?
Vivesto has invested in Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries).
-
When was Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) acquired?
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) was acquired on 25-Mar-2020.
-
Who acquired Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)?
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) was acquired by Elevar Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process